Clearance Summary
AURA CPAP PATIENT INTERFACE received FDA 510(k) clearance under submission number K042130, sponsored by Aeiomed, Inc.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 2004-09-08.
- Submission: K042130
- Applicant / Sponsor: Aeiomed, Inc.
- Clearance pathway: Abbreviated
- Review panel: Anesthesiology
- Device class: Class II
- Regulation citation: 21 CFR 868.5905
- Decision date: 2004-09-08
Classification & Regulation
This clearance is catalogued under FDA product code BZD and 21 CFR 868.5905, within the Anesthesiology review panel as a Class II device.